As the global hematology community prepares for the 67th American Society of Hematology (ASH) Annual Meeting & Exposition, ProcDNA is set to provide timely, actionable insights that help life sciences organizations stay ahead of the latest scientific and commercial developments.

Taking place December 6–9, 2025, at the Orange County Convention Center in Orlando, Florida, ASH 2025 is expected to feature groundbreaking research, clinical trial updates, and emerging therapies that will shape the future of hematology and blood cancer care.

Recognizing that valuable conference learnings extend far beyond the event itself, ProcDNA will be tracking the most impactful announcements, scientific presentations, and industry trends to help organizations transform information into strategic action.

Leveraging its expertise in competitive intelligence, social listening, and advanced analytics, ProcDNA will deliver curated insights that enable pharmaceutical and biotech teams to monitor evolving treatment landscapes, competitor activity, key opinion leader (KOL) engagement, and emerging market dynamics.

Organizations looking to strengthen their conference intelligence and social listening capabilities can also connect with ProcDNA's experts to explore customized insight solutions tailored to their therapeutic areas and business objectives.

Through its AI-powered analytics and life sciences expertise, ProcDNA remains committed to helping organizations make faster, more informed decisions by turning complex scientific data into meaningful business intelligence.